financetom
Business
financetom
/
Business
/
Canadian Pacific Q4 Adjusted Earnings, Revenue Rise; Full-Year EPS Guidance Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canadian Pacific Q4 Adjusted Earnings, Revenue Rise; Full-Year EPS Guidance Set
Mar 11, 2026 2:03 AM

04:25 PM EST, 01/28/2026 (MT Newswires) -- Canadian Pacific Kansas City ( CP ) reported Q4 core adjusted earnings late Wednesday of $1.33 per diluted share, up from $1.29 a year earlier.

Analysts polled by FactSet expected $0.99.

Revenue in the three months ended Dec. 31 rose to $3.9 billion from $2.69 billion a year earlier.

Analysts surveyed by FactSet expected $2.89 billion.

For full-year 2026, the company expects low double-digit core adjusted diluted EPS growth versus 2025 core adjusted diluted EPS of $4.61.

Analysts polled by FactSet expect $3.87.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
McKesson misses quarterly revenue as U.S. pharmaceutical segment weighs
McKesson misses quarterly revenue as U.S. pharmaceutical segment weighs
Aug 7, 2024
Aug 7 (Reuters) - McKesson Corp ( MCK ) reported weaker-than-expected first-quarter revenue on Wednesday due to soft demand for branded and specialty drugs that dragged sales down in its U.S. pharmaceuticals segment. The drug distributor's pharmaceutical segment in the U.S. is its largest unit by revenue that sells drugs used to treat complex conditions such as cancer. The segment...
Revolution Medicines Q2 Loss Narrows
Revolution Medicines Q2 Loss Narrows
Aug 7, 2024
04:58 PM EDT, 08/07/2024 (MT Newswires) -- Revolution Medicines ( RVMD ) reported a Q2 net loss late Wednesday of $0.81 per diluted share, compared with a loss of $0.92 per share a year earlier. Analysts polled by Capital IQ expected a loss of $0.78. The company did not report any revenue in the quarter. For 2024, the clinical-stage oncology...
Innergex Reports Swing to a Q2 Adjusted Loss as Revenue Falls
Innergex Reports Swing to a Q2 Adjusted Loss as Revenue Falls
Aug 7, 2024
04:58 PM EDT, 08/07/2024 (MT Newswires) -- Innergex Renewable Energy ( INGXF ) after hours on Wednesday reports a swing to an adjusted loss for the second quarter. The renewable power producer reported an adjusted loss, excluding most one-time items, of $3.9 million or $0.09 per share, from an adjusted profit of $11.3 million, or $0.10, last year. Revenue and...
Watts Water Technologies Q2 Adjusted Earnings, Revenue Rise
Watts Water Technologies Q2 Adjusted Earnings, Revenue Rise
Aug 7, 2024
04:58 PM EDT, 08/07/2024 (MT Newswires) -- Watts Water Technologies ( WTS ) reported Q2 adjusted earnings late Wednesday of $2.46 per diluted share, up from $2.34 a year earlier. Analysts polled by Capital IQ expected $2.33. Sales for the quarter that ended June 30 were $597.3 million, up from $532.8 million a year earlier. Analysts surveyed by Capital IQ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved